Do analysts recommend MBAI or IVF?

INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than Check-Cap. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer IVF or SINT?

In the previous week, INVO Fertility had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 5 mentions for INVO Fertility and 3 mentions for Sintx Technologies. INVO Fertility's average media sentiment score of 0.99 beat Sintx Technologies' score of 0.96 indicating that INVO Fertility is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment INVO Fertility 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate IVF or QNRX?

INVO Fertility currently has a consensus price target of $20.00, suggesting a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher possible upside, research analysts plainly believe INVO Fertility is more favorable than Quoin Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to IVF or QNRX?

In the previous week, INVO Fertility had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 5 mentions for INVO Fertility and 4 mentions for Quoin Pharmaceuticals. INVO Fertility's average media sentiment score of 0.99 beat Quoin Pharmaceuticals' score of 0.49 indicating that INVO Fertility is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment INVO Fertility 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ALUR or IVF?

In the previous week, INVO Fertility had 4 more articles in the media than Allurion Technologies. MarketBeat recorded 5 mentions for INVO Fertility and 1 mentions for Allurion Technologies. INVO Fertility's average media sentiment score of 0.99 beat Allurion Technologies' score of 0.00 indicating that INVO Fertility is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allurion Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral INVO Fertility 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend NXL or IVF?

INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher possible upside, analysts clearly believe INVO Fertility is more favorable than Nexalin Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer NXL or IVF?

In the previous week, INVO Fertility had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 5 mentions for INVO Fertility and 4 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 0.99 beat INVO Fertility's score of 0.99 indicating that Nexalin Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nexalin Technology 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive INVO Fertility 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

INVO Fertility (IVF) Competitors

$2.45 +1.21 (+97.58%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$2.19 -0.26 (-10.78%)

As of 06/26/2026 07:59 PM Eastern

Compare

IVF vs. MBAI, SINT, QNRX, ALUR, and NXL

Should you buy INVO Fertility stock or one of its competitors? MarketBeat compares INVO Fertility with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with INVO Fertility include Check-Cap (MBAI), Sintx Technologies (SINT), Quoin Pharmaceuticals (QNRX), Allurion Technologies (ALUR), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.

How does INVO Fertility compare to Check-Cap?

Check-Cap (NASDAQ:MBAI) and INVO Fertility (NASDAQ:IVF) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Check-Cap has higher earnings, but lower revenue than INVO Fertility. Check-Cap is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check-Cap	N/A	N/A	$4.14M	-$2.77	N/A
INVO Fertility	$6.84M	0.64	-$25.13M	-$1.85 thousand	N/A

Check-Cap has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.33, meaning that its stock price is 133% more volatile than the broader market.

Check-Cap has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. Check-Cap's return on equity of 0.00% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check-Cap	N/A	N/A	N/A
INVO Fertility	-183.75%	-420.62%	-45.21%

1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 0.7% of INVO Fertility shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, INVO Fertility had 3 more articles in the media than Check-Cap. MarketBeat recorded 5 mentions for INVO Fertility and 2 mentions for Check-Cap. INVO Fertility's average media sentiment score of 0.99 beat Check-Cap's score of 0.43 indicating that INVO Fertility is being referred to more favorably in the news media.

Company	Overall Sentiment
Check-Cap	Neutral
INVO Fertility	Positive

Summary

INVO Fertility beats Check-Cap on 10 of the 15 factors compared between the two stocks.

How does INVO Fertility compare to Sintx Technologies?

INVO Fertility (NASDAQ:IVF) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Sintx Technologies has lower revenue, but higher earnings than INVO Fertility. Sintx Technologies is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84M	0.64	-$25.13M	-$1.85 thousand	N/A
Sintx Technologies	$1.02M	8.13	-$10.36M	-$5.07	N/A

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 0.7% of INVO Fertility shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

INVO Fertility has a net margin of -183.75% compared to Sintx Technologies' net margin of -1,058.60%. Sintx Technologies' return on equity of -366.49% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-183.75%	-420.62%	-45.21%
Sintx Technologies	-1,058.60%	-366.49%	-115.04%

In the previous week, INVO Fertility had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 5 mentions for INVO Fertility and 3 mentions for Sintx Technologies. INVO Fertility's average media sentiment score of 0.99 beat Sintx Technologies' score of 0.96 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
INVO Fertility	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

INVO Fertility currently has a consensus target price of $20.00, suggesting a potential upside of 716.33%. Sintx Technologies has a consensus target price of $9.33, suggesting a potential upside of 386.11%. Given INVO Fertility's higher possible upside, equities research analysts clearly believe INVO Fertility is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

INVO Fertility has a beta of 2.33, indicating that its share price is 133% more volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

Summary

INVO Fertility beats Sintx Technologies on 9 of the 16 factors compared between the two stocks.

How does INVO Fertility compare to Quoin Pharmaceuticals?

INVO Fertility (NASDAQ:IVF) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

INVO Fertility currently has a consensus price target of $20.00, suggesting a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher possible upside, research analysts plainly believe INVO Fertility is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, INVO Fertility had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 5 mentions for INVO Fertility and 4 mentions for Quoin Pharmaceuticals. INVO Fertility's average media sentiment score of 0.99 beat Quoin Pharmaceuticals' score of 0.49 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
INVO Fertility	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quoin Pharmaceuticals has lower revenue, but higher earnings than INVO Fertility. Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84M	0.64	-$25.13M	-$1.85 thousand	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

Quoin Pharmaceuticals has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. INVO Fertility's return on equity of -420.62% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-183.75%	-420.62%	-45.21%
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

INVO Fertility has a beta of 2.33, indicating that its share price is 133% more volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market.

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 0.7% of INVO Fertility shares are held by company insiders. Comparatively, 13.5% of Quoin Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

INVO Fertility beats Quoin Pharmaceuticals on 11 of the 16 factors compared between the two stocks.

How does INVO Fertility compare to Allurion Technologies?

Allurion Technologies (NYSE:ALUR) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 8.1% of Allurion Technologies shares are owned by insiders. Comparatively, 0.7% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Allurion Technologies has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.33, meaning that its stock price is 133% more volatile than the broader market.

Allurion Technologies has higher revenue and earnings than INVO Fertility. Allurion Technologies is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allurion Technologies	$17.21M	0.51	-$7.20M	-$2.03	N/A
INVO Fertility	$6.84M	0.64	-$25.13M	-$1.85 thousand	N/A

In the previous week, INVO Fertility had 4 more articles in the media than Allurion Technologies. MarketBeat recorded 5 mentions for INVO Fertility and 1 mentions for Allurion Technologies. INVO Fertility's average media sentiment score of 0.99 beat Allurion Technologies' score of 0.00 indicating that INVO Fertility is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allurion Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
INVO Fertility	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

INVO Fertility has a net margin of -183.75% compared to Allurion Technologies' net margin of -199.96%. Allurion Technologies' return on equity of 0.00% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allurion Technologies	-199.96%	N/A	-77.13%
INVO Fertility	-183.75%	-420.62%	-45.21%

Allurion Technologies presently has a consensus price target of $45.00, indicating a potential upside of 7,658.62%. INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 716.33%. Given Allurion Technologies' higher probable upside, equities analysts plainly believe Allurion Technologies is more favorable than INVO Fertility.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

INVO Fertility beats Allurion Technologies on 9 of the 17 factors compared between the two stocks.

How does INVO Fertility compare to Nexalin Technology?

Nexalin Technology (NASDAQ:NXL) and INVO Fertility (NASDAQ:IVF) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Nexalin Technology has a beta of 3.8, indicating that its stock price is 280% more volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.33, indicating that its stock price is 133% more volatile than the broader market.

Nexalin Technology has higher earnings, but lower revenue than INVO Fertility. Nexalin Technology is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexalin Technology	$300K	24.35	-$8.22M	-$0.47	N/A
INVO Fertility	$6.84M	0.64	-$25.13M	-$1.85 thousand	N/A

In the previous week, INVO Fertility had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 5 mentions for INVO Fertility and 4 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 0.99 beat INVO Fertility's score of 0.99 indicating that Nexalin Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nexalin Technology	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
INVO Fertility	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher possible upside, analysts clearly believe INVO Fertility is more favorable than Nexalin Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

INVO Fertility has a net margin of -183.75% compared to Nexalin Technology's net margin of -3,018.12%. Nexalin Technology's return on equity of -191.88% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nexalin Technology	-3,018.12%	-191.88%	-166.43%
INVO Fertility	-183.75%	-420.62%	-45.21%

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 25.3% of Nexalin Technology shares are owned by insiders. Comparatively, 0.7% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

INVO Fertility beats Nexalin Technology on 9 of the 16 factors compared between the two stocks.

Get INVO Fertility News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IVF vs. The Competition

Export

Metric	INVO Fertility	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.21M	$40.79M	$6.70B	$12.22B
Dividend Yield	N/A	1.08%	2.67%	6.12%
P/E Ratio	0.00	19.40	25.76	24.17
Price / Sales	0.64	28.24	556.43	98.84
Price / Cash	N/A	18.86	46.99	54.37
Price / Book	0.71	6.58	10.77	6.35
Net Income	-$25.13M	-$20.39M	$3.57B	$337.63M
7 Day Performance	63.33%	3.05%	2.15%	0.06%
1 Month Performance	53.13%	-4.34%	1.06%	-0.15%
1 Year Performance	-98.04%	-8.09%	34.16%	27.55%

INVO Fertility Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IVF INVO Fertility	2.3528 of 5 stars	$2.45 +97.6%	$20.00 +716.3%	-98.0%	$2.21M	$6.84M	N/A	10	News Coverage Earnings Report Gap Down High Trading Volume
MBAI Check-Cap	0.1881 of 5 stars	$1.40 +2.6%	N/A	N/A	$10.17M	N/A	N/A	80	Positive News Short Interest Increase
SINT Sintx Technologies	3.9173 of 5 stars	$2.16 0.0%	$9.33 +332.3%	-39.2%	$9.26M	$738K	N/A	40	Short Interest Decrease Gap Down
QNRX Quoin Pharmaceuticals	1.5949 of 5 stars	$4.66 +4.4%	N/A	-54.3%	$9.20M	N/A	N/A	4	Gap Up
ALUR Allurion Technologies	1.1988 of 5 stars	$0.59 +0.6%	$3.00 +405.6%	-98.4%	$8.90M	$17.21M	N/A	501

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IVF) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

INVO Fertility (IVF) Competitors

IVF vs. MBAI, SINT, QNRX, ALUR, and NXL

How does INVO Fertility compare to Check-Cap?

Summary

How does INVO Fertility compare to Sintx Technologies?

Summary

How does INVO Fertility compare to Quoin Pharmaceuticals?

Summary

How does INVO Fertility compare to Allurion Technologies?

Summary

How does INVO Fertility compare to Nexalin Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IVF vs. The Competition

INVO Fertility Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

INVO Fertility (IVF) Competitors

IVF vs. MBAI, SINT, QNRX, ALUR, and NXL

How does INVO Fertility compare to Check-Cap?

Do analysts recommend MBAI or IVF?

Which has preferable earnings & valuation, MBAI or IVF?

Which has more volatility & risk, MBAI or IVF?

Is MBAI or IVF more profitable?

Do institutionals and insiders hold more shares of MBAI or IVF?

Does the media favor MBAI or IVF?

Summary

How does INVO Fertility compare to Sintx Technologies?

Which has higher earnings & valuation, IVF or SINT?

Do insiders & institutionals hold more shares of IVF or SINT?

Is IVF or SINT more profitable?

Does the media prefer IVF or SINT?

Do analysts recommend IVF or SINT?

Which has more risk and volatility, IVF or SINT?

Summary

How does INVO Fertility compare to Quoin Pharmaceuticals?

Do analysts rate IVF or QNRX?

Does the media refer more to IVF or QNRX?

Which has better earnings & valuation, IVF or QNRX?

Is IVF or QNRX more profitable?

Which has more volatility and risk, IVF or QNRX?

Do insiders & institutionals believe in IVF or QNRX?

Summary

How does INVO Fertility compare to Allurion Technologies?

Do institutionals & insiders believe in ALUR or IVF?

Which has more risk & volatility, ALUR or IVF?

Which has stronger valuation & earnings, ALUR or IVF?

Does the media prefer ALUR or IVF?

Is ALUR or IVF more profitable?

Do analysts prefer ALUR or IVF?

Summary

How does INVO Fertility compare to Nexalin Technology?

Which has more volatility & risk, NXL or IVF?

Which has better valuation & earnings, NXL or IVF?

Does the media prefer NXL or IVF?

Do analysts recommend NXL or IVF?

Is NXL or IVF more profitable?

Do insiders and institutionals believe in NXL or IVF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IVF vs. The Competition

INVO Fertility Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools